Opioid Treatment Programmes
Cross-source consensus on Opioid Treatment Programmes from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Benefits
Risks & contraindications
Highlighted claims
- Treatment retention is presented as a major determinant of opioid treatment programme effectiveness. — Qualitative evidence of service user experiences and perspectives on long-acting injectable buprenorphine for opioid treatment: protocol for a scoping review
- Service user preferences should play a central role in choosing between methadone and buprenorphine. — Qualitative evidence of service user experiences and perspectives on long-acting injectable buprenorphine for opioid treatment: protocol for a scoping review
- Service users often face policies and practices that reduce their agency and therapeutic choice. — Qualitative evidence of service user experiences and perspectives on long-acting injectable buprenorphine for opioid treatment: protocol for a scoping review
- Collaborative, individualised, non-judgemental, person-centred care is identified as characteristic of more effective opioid treatment programmes. — Qualitative evidence of service user experiences and perspectives on long-acting injectable buprenorphine for opioid treatment: protocol for a scoping review
- Rigid and restrictive opioid treatment policies can undermine engagement, retention, and sustainability. — Qualitative evidence of service user experiences and perspectives on long-acting injectable buprenorphine for opioid treatment: protocol for a scoping review